Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/28/2010CA2755328A1 Use of nifuratel to treat infections caused by atopobium species
10/28/2010CA2754702A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010CA2748414A1 Inhibitors of bruton's tyrosine kinase
10/28/2010CA2745596A1 Thiazolyl-benzimidazoles
10/28/2010CA2744947A1 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/28/2010CA2743801A1 Rifamycin derivatives
10/27/2010EP2243833A1 Method for the treatment of acute myeloid leukemia
10/27/2010EP2243809A1 Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243781A1 Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243778A1 Piperidine derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243774A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/27/2010EP2243773A1 Platinum complex compound and utilization of the same
10/27/2010EP2243772A1 Novel P2X7R antagonists and their use
10/27/2010EP2243771A2 Composition and method for promoting hair growth
10/27/2010EP2243766A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2243486A1 Adrenomedullin production enhancer
10/27/2010EP2243485A1 Anti-viral agents, anti-viral fibers and anti-viral fiber structures
10/27/2010EP2243484A2 Controlled release oxycodone compositions
10/27/2010EP2243483A1 Amlodipine salt compositions for topical application
10/27/2010EP2243482A1 Use of nifuratel to treat infections caused by atopobium species
10/27/2010EP2243481A1 Irak kinase family as novel drug target for Alzheimer
10/27/2010EP2243480A1 Pharmaceutical formulations comprising oxaliplatin and an acid.
10/27/2010EP2243479A2 Novel amide and amidine derivates and uses thereof
10/27/2010EP2243478A1 Pharmaceutical composition combining an antiarthritic agent and an interleukin-1 inhibiting agent, which can be used to control and treat osteoarthritis and related diseases
10/27/2010EP2243477A1 Paracetamol for parenteral application
10/27/2010EP2243476A1 Compounds for the treatment of mitochondrial diseases
10/27/2010EP2243475A1 Combination of memantine and donepezil for treatment of CNS disorders
10/27/2010EP2243474A1 Propective effect of thymoquinome in sepsis
10/27/2010EP2243471A1 Matrix for sustained, invariant and independent release of active compounds
10/27/2010EP2243468A1 Orally Disintegrating Dimebolin Compositions
10/27/2010EP2242838A1 Stem-like cells and method for reprogramming adult mammalian somatic cells
10/27/2010EP2242759A1 Compounds
10/27/2010EP2242758A1 Crystalline form of abacavir that is essentially free of solvent
10/27/2010EP2242757A1 Pyrazolopyridines as kinase inhibitors
10/27/2010EP2242755A1 Pyrrolopyridines as kinase inhibitors
10/27/2010EP2242754A1 Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2010EP2242753A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
10/27/2010EP2242752A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
10/27/2010EP2242751A1 Heterocyclic derivatives as hepatitis c virus inhibitors
10/27/2010EP2242750A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors
10/27/2010EP2242749A1 Novel pyridinones and pyridazinones
10/27/2010EP2242748A1 Therapeutic disulfide compounds for treating pain and diabetes
10/27/2010EP2242746A1 Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
10/27/2010EP2242745A1 Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof
10/27/2010EP2242743A1 Aminopyrazole derivatives
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242741A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
10/27/2010EP2242740A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
10/27/2010EP2242738A1 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
10/27/2010EP2242737A1 Pregabalin salts
10/27/2010EP2242494A1 Methods of making low molecular weight heparin compositions
10/27/2010EP2242493A1 Derivatives of gefitinib
10/27/2010EP2242492A1 Antitumoral agents with a benzophenanthridine structure and formulations containing them
10/27/2010EP2242491A1 Novel use of 3,3'-diindolylmethane
10/27/2010EP2242490A1 Mixture of citric flavonoids to improve ruminal fermentation
10/27/2010EP2242488A2 Amino acid derivatives used as pharmaceutical substances
10/27/2010EP2242485A2 Oral controlled release tablet
10/27/2010EP2242483A1 Raloxifene composition
10/27/2010EP2242482A2 Anti - retroviral combination
10/27/2010EP2242476A2 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
10/27/2010EP2242367A2 Rel inhibitors and methods of use thereof
10/27/2010EP2242359A1 Synthesis of resorcylic acid lactones useful as therapeutic agents
10/27/2010EP2167016B1 Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof
10/27/2010EP2099761B1 Antibacterial quinoline derivatives
10/27/2010EP2091938B1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
10/27/2010EP2046800B1 6-carboxy-normorphinan derivatives, synthesis and uses thereof
10/27/2010EP2041145B1 Azatricyclic compounds and their use
10/27/2010EP2007735B1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
10/27/2010EP1922320B1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/27/2010EP1907399B1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
10/27/2010EP1891057B1 Azabicyclo[3.1.0]hexane derivaives as dopamin d3 receptor modulators
10/27/2010EP1812418B1 Dibenzosuberone derivatives
10/27/2010EP1789044B1 Phenylaminopyridines and phenylaminopyrazines
10/27/2010EP1742634B1 Polycyclic pyrimidines as potassium ion channel modulators
10/27/2010EP1720557B1 Rapidly disintegrating taste-masked tablet
10/27/2010EP1601970B1 Detection, monitoring and treatment of cancer
10/27/2010EP1567155B1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010EP1487877B1 Compositions and methods for the diagnosis of tumors
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1386914B1 Halogenated quinoline derivatives and ectoparasite controllers
10/27/2010EP1383742B1 Synthesis and methods of use of tetrahydroindolone analogues and derivatives
10/27/2010EP1305036B1 Nutritional composition
10/27/2010EP1171124B2 Anthelmintic compositions
10/27/2010EP1112088B1 Method for detecting connective tissue growth factor for diagnosing a renal disorder
10/27/2010EP0975609B1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
10/27/2010EP0681475B1 Therapeutic inhibitors of vascular smooth muscle cells
10/27/2010CN201612864U 壳聚糖包覆药物缓释微球 Chitosan microspheres coated drug delivery
10/27/2010CN201612837U 一种前列腺素及其衍生物的预充式注射剂 A prostaglandin derivative and a pre-filled injection
10/27/2010CN1993356B Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
10/27/2010CN1953670B Composition, use of a composition and a method for treating obesity
10/27/2010CN1918156B Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
10/27/2010CN1912141B Identification of genes
10/27/2010CN1899295B Use of kakonein in preparing medicine for treating endometriosis
10/27/2010CN1898231B Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
10/27/2010CN1887290B Lincomycin hydrochloride composition and its prepn
1 ... 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 ... 7860